Characterization of mutational 'coldspots' in the cancer genome

byInstitute for Research in Biomedicine (IRB Barcelona)Credit: Pixabay/CC0 Public DomainMutations are the changes in the DNA that gradually occur in human cells as they replicate, and the organi

Updated on: April 28,2024

Characterization of mutational 'coldspots' in the cancer genome

byInstitute for Research in Biomedicine (IRB Barcelona)Credit: Pixabay/CC0 Public DomainMutations are the changes in the DNA that gradually occur in human cells as they replicate, and the organi

Updated on:April 28,2024

Few cancer survivors fully adherent to ACS nutrition and physical activity guidelines

by Elana GotkineOnly 4% of cancer survivors are fully adherent to current American Cancer Society (ACS) nutrition and physical activity guidelines, according to a studypublishedonline Apri

Updated on: April 28,2024

Few cancer survivors fully adherent to ACS nutrition and physical activity guidelines

by Elana GotkineOnly 4% of cancer survivors are fully adherent to current American Cancer Society (ACS) nutrition and physical activity guidelines, according to a studypublishedonline Apri

Updated on:April 28,2024

New insight into combating drug-resistant prostate cancer

byUniversity of Eastern FinlandCredit:Nucleic Acids Research(2023). DOI: 10.1093/nar/gkad1126Recent research from the University of Eastern Finland sheds light on the significance of

Updated on: April 28,2024

New insight into combating drug-resistant prostate cancer

byUniversity of Eastern FinlandCredit:Nucleic Acids Research(2023). DOI: 10.1093/nar/gkad1126Recent research from the University of Eastern Finland sheds light on the significance of

Updated on:April 28,2024

Direct-acting antivirals still underused in hep C-related liver cancer

by Lori SolomonDirect-acting antiviral agents (DAAs) remain underutilized in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), according to a study presented at The Liver M

Updated on: April 10,2024

Direct-acting antivirals still underused in hep C-related liver cancer

by Lori SolomonDirect-acting antiviral agents (DAAs) remain underutilized in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), according to a study presented at The Liver M

Updated on:April 10,2024

Specialised molecular profiling could allow more accurate prognosis and treatment of brain tumours

by Medical University of ViennaCredit: CC0 Public DomainMeningiomas, a type of brain tumour, are usually easy to treat. However, there are a few subtypes that follow a very aggressive course and

Updated on: April 01,2024

Specialised molecular profiling could allow more accurate prognosis and treatment of brain tumours

by Medical University of ViennaCredit: CC0 Public DomainMeningiomas, a type of brain tumour, are usually easy to treat. However, there are a few subtypes that follow a very aggressive course and

Updated on:April 01,2024

Study may explain why some triple-negative breast cancers are resistant to chemotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainTriple-negative breast cancer (TNBC) is an aggressive form of the disease accounting for 12 to 18 percent of breast can

Updated on: June 28,2024

Study may explain why some triple-negative breast cancers are resistant to chemotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainTriple-negative breast cancer (TNBC) is an aggressive form of the disease accounting for 12 to 18 percent of breast can

Updated on:June 28,2024

Finally, a potential new approach against KRAS-driven lung cancer

by CU Anschutz Medical CampusAlison Bauer, PhD, and colleagues identify MUC5AC as a new target in KRAS-driven lung cancer. Credit: University of Colorado Cancer CenterThe previous decade has seen

Updated on: March 21,2024

Finally, a potential new approach against KRAS-driven lung cancer

by CU Anschutz Medical CampusAlison Bauer, PhD, and colleagues identify MUC5AC as a new target in KRAS-driven lung cancer. Credit: University of Colorado Cancer CenterThe previous decade has seen

Updated on:March 21,2024

New preclinical model could accelerate research on thymic cancer

byWeill Cornell Medical CollegeCredit: AI-generated imageA new preclinical model for thymic cancer developed by Weill Cornell Medicine investigators has revealed insights into how a common mutat

Updated on: January 12,2024

New preclinical model could accelerate research on thymic cancer

byWeill Cornell Medical CollegeCredit: AI-generated imageA new preclinical model for thymic cancer developed by Weill Cornell Medicine investigators has revealed insights into how a common mutat

Updated on:January 12,2024

Study reveals how chronic blood cancer transitions to aggressive disease

by Julia Evangelou Strait,Washington University School of MedicineA study from Washington University School of Medicine in St. Louis suggests a strategy for preventing a chronic, slow-growing ty

Updated on: February 23,2024

Study reveals how chronic blood cancer transitions to aggressive disease

by Julia Evangelou Strait,Washington University School of MedicineA study from Washington University School of Medicine in St. Louis suggests a strategy for preventing a chronic, slow-growing ty

Updated on:February 23,2024

Researchers design gene therapy that can effectively target glioblastoma

by Brigham and Women's HospitalGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Glioblastoma (GBM), an aggressive brain cancer, is notoriously resistant to treatment, with recurr

Updated on: June 06,2024

Researchers design gene therapy that can effectively target glioblastoma

by Brigham and Women's HospitalGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Glioblastoma (GBM), an aggressive brain cancer, is notoriously resistant to treatment, with recurr

Updated on:June 06,2024

New gene found for a deadly childhood cancer offers possibility of targeted drug therapy

by Children's Cancer Institute AustraliaCredit: CC0 Public DomainNeuroblastoma accounts for 15% of total childhood cancer deaths. The survival rate of high-risk neuroblastoma patients is 50%.For t

Updated on: March 12,2024

New gene found for a deadly childhood cancer offers possibility of targeted drug therapy

by Children's Cancer Institute AustraliaCredit: CC0 Public DomainNeuroblastoma accounts for 15% of total childhood cancer deaths. The survival rate of high-risk neuroblastoma patients is 50%.For t

Updated on:March 12,2024

The long-term financial toll of breast cancer

by Johns Hopkins University Bloomberg School of Public HealthMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainThe financial fallout from breast can

Updated on: March 01,2024

The long-term financial toll of breast cancer

by Johns Hopkins University Bloomberg School of Public HealthMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainThe financial fallout from breast can

Updated on:March 01,2024